IL6 and neoplasm: This suggests that, apart from the regulatory effects of IL-6 on VEGF production, other mechanisms are responsible for the deleterious effects of high serum IL-6 levels on tumour growth, thus explaining their strong correlation with prognosis in metastatic breast cancer patients.